Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hokusai VTE Cancer
NCT02073682Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of edoxaban in venous thromboembolism (VTE), sponsored by Daiichi Sankyo Co., Ltd.. Started Jul 2015; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02073682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02073682.